Optimization of preparation of morphofunctional endometrial structure in assisted reproductive technology programs
Keywords:endometrium, assisted reproductive technologies, arginine, Tivortin®
The study on the efficiency of the drug Tivortin® containing arginine in cycles of assisted reproductive technology (ART ) to restore the ability of endometrial implant and improve the effectiveness of ART was performed. The study included 31 patients in the main group (at the second stage of the complex therapy they received Tivortin®) and 40 women in the control group (receiving vitamin therapy),
suffering from infertility caused chronic inflammatory diseases of the pelvic organs and unsuccessful attempts ART in the anamnesis. The study showed that the use drug Tivortin® as adjuvant therapy before ART cycles improves uterine blood flow and restores the morphofunctional state of endometrium, significantly increases the possibility of implantation endometrium, that is increases the rate of pregnancy
- Golovchenko, Y.I., Treshchynskaia, M.A. “Review of modern concepts of endothelial dysfunction.” Consilium Medicum Ukraina, 11(2008): 38-40.
- Gurevich, M.A., Sturov, N.V. “Deficiency of nitric oxide and the maintenance of vascular homeostasis: role mononitrates and cytoprotection problems.” The Difficult Patient, 3(2006): 23–29.
- Hiulmamedova, I.D. “Problems of implantation in the IVF program .” Medical Pharmacy News. Gynecology, 253(2008): 17–27.
- Yelskyi, V.N., Vatutin, N.T., Kalinkina, N.V., Salakhova, A.M. “Role of endothelial dysfunction in the genesis of cardiovascular diseases.” J. Phys. AM S of Ukraine, 14(1) (2008): 51-62.
- Slobodskyi, V.A. “Experience of TivortinR aspartate in patients with stable exertional angina.” Ukrainian Medical Journal, 5(73) (2009): 40-43.
- Sudoma, I.A., Zadorozhna, T.D., Berestovoi, O.A. “Endometrial NK cells in patients with implantation failure in in vitro fertilization cycles.” Women’s Health, 1(17) (2004): 82–86.
- Fedorova, E.V., Lipman, A.D., Omelianenko, A.I., Shakunova, V.P. “Study of uterine and ovarian blood flow in patients with infertility during the treatment by assisted reproductive technology methods. The study of blood flow of uterine and endometrium.” Ultrasonic and Functional Diagnostics, 3(2002): 126-135.
- Bryan, N.S., Bian, K., Murad, F. “Discovery of the nitric oxide signaling pathway and targets for drug development.” Frontiers in Bioscience, 14(2009): 1–18.
- C hatterjee, A., Catravas, J.D. “Endothelial nitric oxide (NO) and its pathophysiologic regulation.” Vascul Pharmacol, 49(4–6) (2008): 134–140.
- Li, T.C. “Evidencebased management of the couple with recurrent implantation failure.” ESHRE (2012).
- M acklon, N. “Laboratory: The embryoendometrial interface – role in implantation/developmental success.” The contribution of the endometrium University of Southampton, Academic Unit of Human Health and Development Mailpoint. European Society of Human Reproduction and Embryology: 29th Annual Meeting. Paramedical invited session. London, United Kingdom, 7–10 July 2013.
- Zaidi, J., Campbell, S., Pittrof, R., Tan, S.L. “Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in vitro fertilization program.” Ultrasound Obstet Gynecol, 6(3) (1995): 191–198.
- Sundstrom, P. “Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4 mm.” Hum Reprod, 13(6) (1998): 1550–1552.
- Gkaliagkousi, E., Ritter, J., Ferro, A. “Platelet-derived nitric oxide signaling and regulation.” Circ Res, 101(7) (2207): 654–662.
How to Cite
Copyright (c) 2015 Е. Н. Борис, Л. В. Сусликова, В. В. Каминский, Л. Н. Онищик, А. В. Сербенюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.